baber/WOPTO huggingface dataset:
Patent WO-2019154837-A1 (WO)
Inventor: MÜLLER-BRUHN RONJA
IPC: A61N2/00
Filed: 2019-02-06
Abstract: Un dispositif d'induction électromagnétique (2) pour activer un tissu cible dans un corps humain ou animal via son système musculaire ou neuronal comprend : (i) un générateur de champ électromagnétique (21) ayant une conception de bobine (211) configuré pour générer un champ électromagnétique (212) ayant une forme ciblée (213), (ii) un agencement de montage (22) maintenant la conception de bobine (211) du générateur de champ électromagnétique (21) au niveau du corps humain ou animal, (iii) un élément capteur (4) configuré pour détecter une activation du tissu cible, (iv) un mécanisme de réglage de champ électromagnétique (21) configuré pour ajuster automatiquement la position du champ électromagnétique (212) généré par la conception de bobine (211) et pour ajuster l'intensité du champ électromagnétique (212) généré par la conception de bobine, et (v) une unité d'étalonnage (31) en communication avec l'élément capteur (4) et avec le mécanisme de réglage de champ électromagnétique (21). L'unité d'étalonnage (31) est configurée (a) pour commander le mécanisme de réglage de champ électromagnétique (21) pour faire varier automatiquement la position du champ électromagnétique (212) généré par la conception de bobine (211) et pour faire varier automatiquement l'intensité du champ électromagnétique (212) généré par la conception de bobine, (b) pour recevoir un signal de rétroaction d'activation provenant de l'élément capteur (4) lors de la détection de l'activation du tissu cible, et (c) pour commander le mécanisme de réglage de champ électromagnétique (21) pour arrêter automatiquement une variation de la position du champ électromagnétique (212) généré par la conception de bobine (211) lorsque le signal de rétroaction d'activation est reçu et pour arrêter automatiquement une variation de l'intensité du champ électromagnétique (212) généré par la conception de bobine (211) lorsque la rétroaction d'activation est reçue.
Patent WO-2019170458-A1 (WO)
Inventor: DE CLERCQ LUDWIG ERASMUS
IPC: H05B44/00
Filed: 2019-02-25
Abstract: Ein Synchronkonverter (10) zum Betreiben zumindest einer LED (41) umfasst: Versorgungs- und Lastseiten (12, 13) mit jeweiligen Schaltmitteln (14, 15); Erfassungsmittel (11C, 16) zum Erfassen einer LED-Spannung (17); und eine Steuereinrichtung zum Ansteuern der Schaltmittel (14, 15) in einem Gegentakt, welcher von der erfassten LED-Spannung (17) abhängt. Dabei ist die Steuereinrichtung dazu eingerichtet, das Schaltmittel (14) auf der Versorgungsseite (12) mit einer jeweiligen konstanten Einschaltzeit (T p ) für einen jeweiligen aus einer Mehrzahl von vorgegebenen Wertebereichen für die erfasste LED-Spannung (17) anzusteuern, in den die erfasste LED-Spannung (17) fällt.
Patent WO-2019162532-A1 (WO)
Title: Improved pneumovirus reverse genetics
Inventor: LUDLOW MARTIN
IPC: C12N15/86
Filed: 2019-02-26
Abstract: The invention provides a reverse genetics system combining bacterial artificial chromosome (BAC) recombination-mediated mutagenesis with reverse genetics for a negative strand RNA virus classified in the family Pneumoviridae, such as a Orthopneumovirus and/or Metapneumovirus, that is also suitable for rescuing pneumoviruses having a nucleotide G gene duplication. In one particular embodiment, a respiratory syncytial virus (RSV) reverse genetics rescue system for strains encoding a nucleotide duplication in the G gene that are notoriously unstable in bacterial expression systems is herewith established. An important advantage of this system is that RSV antigenomic cDNA is stabilized in the vector, allowing reliable rescue of recombinant RSVs with sequences identical to clinical isolates. Herewith, the invention provides a method and means to rapidly mechanistically investigate point mutations, e.g. to be used in a human challenge study, or in an antiviral drug screen, performed with a clinically up-to-date Pneumovirus isolate.
Patent WO-2019170631-A1 (WO)
Inventor: KNOLL LARS
IPC: H01L29/861
Filed: 2019-03-05
Abstract: A power semiconductor device comprises: a wide-bandgap semiconductor layer (1) extending in a lateral direction and comprising an active region (AR) and a termination region (TR) surrounding the active region (AR); a first recess (9) recessed from the first main side (2) in the termination region (TR) and surrounding the active region (AR); a field plate (5) on the first main side (2) of the wide-bandgap semiconductor layer (1) and exposing a first portion of the wide-bandgap semiconductor layer (1) in the termination region (TR); and a sidewall (9e) of the first recess adjacent to the active region (AR) being laterally aligned with a circumferential edge (5e) of the field plate (5).
Patent WO-2019185752-A1 (WO)
Title: Exercise device
Inventor: ALLEN THOMAS
IPC: A63B23/035
Filed: 2019-03-27
Abstract: An exercise device for use by a user in pulling their upper body up by their arms from a surface to strengthen their back, arms, shoulders, and core muscles wherein the device comprises two supports wherein each support comprises a handle for gripping by the user and a shaft for supporting the handle at a height above a surface such that the height is sufficient to suit the length of a user's arms; an exercise device kit which comprises the exercise device and one or more additional handles; and a method for a user to exercise with an exercise device according to the invention which method comprises the steps of: (a) Placing each support in a vertical or near vertical orientation on either side of the user's upper body whilst the user is lying on a surface; (b) Gripping the handles; and (c) Pulling downwards such that the user tilts at least their upper body off the surface.
Patent WO-2019206794-A1 (WO)
Title: AN IoT QoS MONITORING SYSTEM AND METHOD
Inventor: CARROLL BRIAN
IPC: H04W24/06
Filed: 2019-04-18
Abstract: Performance of a communications device (3) with a processor, a memory, and a SIM (4) in a wireless communication network is tested to provide a range of QoS KPIs. A test server (1) sends a payload to the device modem (3), the size of which has been computed to avoid adversely affecting real time performance. The modem uses the payload to fill a buffer (6) of restricted size in the memory, the buffer being smaller than the payload. The modem processor signals the SIM (4) to indicate that data is available in the buffer, and the SIM (4) instructs the processor to purge the buffer. There are repeated cycles until all of the payload has been written to the buffer and purged. The buffer (6) signals the test server (1) to indicate that all of the payload has been written to the buffer and purged, and the server (1) determines a time duration from initial download of the payload to final purging as a downlink performance indicator.
Patent WO-2019211140-A1 (WO)
Title: Holding device configured to support a plurality of medical containers such as syringes
Inventor: NICOLAS MAXIME
IPC: A61M5/00
Filed: 2019-04-24
Abstract: This holding device (1) comprises: a supporting plate (10), said supporting plate (10) having an upper face(10a), a lower face (10b) opposite said upper face (10a), a plurality of openings (20) arranged according to a predetermined pattern and each configured to receive a barrel of one of said medical containers, a plurality of reinforcing ribs (30) protruding from at least one of said upper and lower faces (10a, 10b) and extending between adjacent openings (20) of said plurality of openings (20), and the plurality of reinforcing ribs (30) comprises at least one oblique rib (310c) extending obliquely relative to a longitudinal direction (X) of the supporting plate (10) from one side to another side of the supporting plate (10) and between two different pairs of adjacent peripheral openings (20).
Patent WO-2019207111-A1 (WO)
Title: Yeast proteins
Inventor: MENIN RUDY
IPC: C12N1/06
Filed: 2019-04-26
Abstract: The present invention relates to a method for obtaining yeast proteins comprising the following steps: a) providing a yeast cream; b) exposing this yeast cream to a thermal plasmolysis at a temperature between 70 and 95°C for a period between 30 seconds and 4 hours, preferably between 1 minute and 3 hours, more preferably between 40 minutes and 2 hours; b') separating the insoluble fraction and the soluble fraction; c) subjecting the insoluble fraction to the activity of at least one ribonuclease and a glucanase, sequentially or simultaneously, at a temperature between 40 and 65°C, preferably 60°C, for a period between 8 and 24 hours, preferably 18 hours; d) separating the insoluble fraction from the soluble fraction; wherein the insoluble fraction collected in step d) has no taste, having a nucleotide content less than 3% and a true protein content of at least 72%. Step b') is optional. In this case, the entirety of the composition obtained after thermal plasmolysis of the yeast cream is subjected to enzymatic activity.
Patent WO-2019219664-A1 (WO)
Title: Determination of location-specific weather information for agronomic decision support
Inventor: WAHABZADA MIRWAES
IPC: G01W1/10
Filed: 2019-05-14
Abstract: A method performed by at least one apparatus is inter alia disclosed, said method comprising: obtaining weather model data indicative of location-specific weather information for a first set of locations (26) on a first grid (28); obtaining an area of interest (30) associated to at least one user (32); obtaining and/or determining a second set of locations (34) based on a second grid (36) within said area of interest (30); obtaining measurement data on location-specific weather information of a measurement device associated to said at least one user located at a measurement location (38) within and/or proximate to said area of interest (30); and determining, based on at least said obtained weather model data and said obtained measurement data, location-specific weather information for said second set of locations (34) based on said second grid (36).
Patent WO-2019234032-A1 (WO)
Title: Mikroemulsion zur dermalen hyposensibilisierung mit allergenen
Inventor: KISELMANN CHRISTOPHER
IPC: A61K9/107
Filed: 2019-06-04
Abstract: Die Erfindung betrifft die Bereitstellung einer Mikroemulsion enthaltend mindestens ein Allergen für die Hyposensibilisierung eines menschlichen oder tierischen Patienten gegen mindestens ein Allergen wie z.B. Bienengift, Wespengift, Pollenallergene, Allergene von Hausstaubmilben, Tierallergene oder Nahrungsmittelallergene mit einer Mikroemulsion, so dass eine dermale Applikation der Allergene möglich ist. Die Mikroemulsion umfasst PEG-8 caprylic/capric glyceride, Polyglyceryldioleat sowie eine Wasserphase, eine Ölphase und darin mindestens ein dispergiertes Allergen. In vivo-Experimente zeigen, dass mit dieser Mikroemulsion das Allergen das Stratum corneum durchdringt und in den menschlichen oder tierischen Körper gelangt. Die Induktion von Allergentoleranz durch diese innovative Art der Hyposensibilisierung und damit die klinische Wirksamkeit ist bereits anhand von reduzierten Temperaturabfällen in vivo im Mausmodell dargelegt.
Patent WO-2020001955-A1 (WO)
Inventor: HAAS MICHAEL
IPC: C01B33/107
Filed: 2019-06-07
Abstract: La présente invention concerne un procédé de préparation de chlorosilanes partiellement hydrogénés par hydrogénation sélective avec un composé de formule R2AIH, dans laquelle R est un hydrocarbure ramifié ou cyclique. La présente invention concerne en outre des chlorosilanes partiellement hydrogénés préparés avec ledit procédé, en particulier des chlorosilanes partiellement hydrogénés représentés par la formule Cl3SiSi(SiH3)3, (Cl3Si)2Si(SiH3)2 ou HSi(SiH3)2SiCI3.
Patent WO-2019238644-A1 (WO)
Title: Resonating loudspeakers and related systems and methods
Inventor: KATZ SHELLEY
IPC: H04R7/26
Filed: 2019-06-11
Abstract: The present application relates to an improved flat panel loudspeaker design. According to some aspects, the loudspeaker may include a flat panel, and a driving unit coupled to the flat panel configured to produce resonant behavior in the flat panel according to an electrical signal received by the driving unit. One or more pieces of reticulated foam may be mechanically coupled to the flat panel, and in some cases may cover the entire surface of the flat panel.
Patent WO-2020002001-A1 (WO)
Title: Hochdruckreinigungsvorrichtung, reinigungsdispersion und anordnung hochdruckreinigungsvorrichtung zu oberfläche
Inventor: SATTLER DR ANDREAS
IPC: B05B7/14
Filed: 2019-06-13
Abstract: Die Erfindung betrifft eine Hochdruckreinigungsvorrichtung (1; 101) zum materialschonenden Reinigen von mit Feinpartikeln verschmutzten Oberflächen, insbesondere Kraftfahrzeugoberflächen (2), mit einer Hochdruckpumpe (4) zum Fördern eines Reinigungsprodukts zu einer Hochdruckstrahldüse (8), an welcher das Reinigungsprodukt in einem Hochdruckstrahl (10) austritt, wobei das Reinigungsprodukt eine Reinigungsdispersion (6) mit einem Trägerfluid (14) und mit festen Reinigungspartikeln (12; 212) mit einer Dichte zwischen 0,8 g/cm 3  und 3,5 g/cm 3 , insbesondere zwischen 0,9 g/cm 3  und 2,2 g/cm 3 , aufweist und die Hochdruckreinigungsvorrichtung (1; 101) derart konfiguriert ist, dass ein Reinigungspartikel (12; 212) bei Austritt aus der Hochdruckstrahldüse eine kinetische Energie von mindestens 1 - 10 -10  J und maximal von 2 - 10 -4  J, bevorzugt von mindestens 2 - 10 -9  J und maximal 7-10 -5  J, und ganz besonders bevorzugt zwischen mindestens 4 - 10 -7  J und maximal 9 - 10 -6  J aufweist. Daneben betrifft die Erfindung eine Reinigungsdispersion für eine Hochdruckreinigungsvorrichtung sowie eine Anordnung von einer Hochdruckreinigungsvorrichtung und von einer zu reinigenden Oberfläche gemäß den nebengeordneten Ansprüchen.
Patent WO-2019243236-A1 (WO)
Title: Nouvelles combinaisons de médicaments anticancéreux
Inventor: FRESQUET ARNAU VICENTE JOSÉ
IPC: A61P35/00
Filed: 2019-06-17
Abstract: L'invention concerne une combinaison comprenant : A) un composé de formule (I), ou un sel pharmaceutiquement ou vétérinairement acceptable associé, ou tout stéréoisomère ou mélange de stéréoisomères, soit du composé de formule (I), soit de l'un quelconque des sels pharmaceutiquement ou vétérinairement acceptables associés, dans laquelle L, X, R1, R2, R3 et R4 sont tels que définis dans la description ; et B) un médicament choisi dans le groupe constitué par : i) un inhibiteur de point de contrôle immunitaire, ii) un inhibiteur d'une protéine anti-apoptotique, et iii) un agent chimiothérapeutique autre qu'un inhibiteur d'une protéine anti-apoptotique et un inhibiteur de point de contrôle immunitaire ; et des compositions pharmaceutiques ou vétérinaires, et un emballage ou un kit d'éléments le comprenant. L'invention concerne également la combinaison, la composition ou un conditionnement ou un kit d'éléments à utiliser dans le traitement et/ou la prévention du cancer.
Patent WO-2020002028-A1 (WO)
Title: Vcsel array with small pulse delay
Inventor: WEIGL ALEXANDER
IPC: H01S5/42
Filed: 2019-06-17
Abstract: The invention describes a Vertical Cavity Surface Emitting Laser (VCSEL) array (100) comprising at least two VCSEL sub-arrays, wherein each VCSEL sub-array comprises a multitude of VCSELs arranged on a substrate (110), wherein the at least two VCSEL sub-arrays are electrically contacted by means of a first electrical contact arrangement (105, 107) common to the VCSELs within a respective VCSEL sub-array, and a second electrical contact arrangement (150, 155), wherein the second electrical contact arrangement (150, 155) comprises a multitude of second electrical contacts (150), each second electrical contact (150) contacting a respective single VCSEL within the respective VCSEL sub-array individually, wherein each second electrical contact (150) comprises a second metal- semiconductor interface to a second semiconductor layer of an associated VCSEL of the multitude of VCSELs, wherein the second electrical contacts (150) are arranged to electrically pump the associated VCSEL along a current path to the first electrical contact arrangement (105, 107), wherein the current paths between the first electrical contact arrangement (105, 107) and the second electrical contacts (150) via the multitude of VCSELs are characterized by at least one symmetry selected out of the group of rotation symmetry, mirror symmetry and translation symmetry. The invention further relates to a light emitting device comprising such a VCSEL array (100), a time of flight camera comprising such a light emitting device or VCSEL array (100) and a method of manufacturing the VCSEL array (100).
Patent WO-2020002272-A1 (WO)
Title: Kit of parts comprising a cable gland, a wire transport element and a housing, system made of such a kit, and method for functionally connecting the system
Inventor: GIELEN VINCENT
IPC: F21V23/00
Filed: 2019-06-25
Abstract: The invention provides a kit of parts, especially for a lighting system with a light generated device hosted in a housing, the kit of parts comprising (i) a cable gland (100) comprising a cable gland body (110) and a sealing nut (120) for the cable gland body (110), wherein the cable gland (100) is configured for hosting an electrical cable (10) over at least part of a cable length (L) of the electrical cable (10), wherein the electrical cable (10) comprises an electrically conductive wire (11), wherein the cable gland (100) has a cable gland length (L2), and (ii) a wire transport element (2000) comprising a wire transport connector facility (2220) for hosting a part of a functional device electrically conductive wire (311), wherein the shape of the wire transport element (2000) is such that the wire transport element (2000) can be transported through the cable gland (100) over at least part of the cable gland length (L2).
Patent WO-2020002494-A1 (WO)
Title: Means and methods for increased protein expression by use of transcription factors
Inventor: ZAHRL RICHARD
IPC: C12N15/09
Filed: 2019-06-27
Abstract: The present invention is in the field of recombinant biotechnology, in particular in the field of protein expression. The invention generally relates to a method of increasing the yield of a protein of interest (POI) in a eukaryotic host cell, preferably a yeast, by overexpressing at least one polynucleotide encoding at least one transcription factor of the present invention, preferably Msn4/2. The invention relates further to a recombinant eukaryotic host cell for manufacturing a POI, wherein the host cell is engineered to overexpress at least one polynucleotide encoding at least one transcription factor as well as the use of the host cell for manufacturing a POI.
Patent WO-2020038641-A1 (WO)
Inventor: KUTTNER ELISABETH
IPC: C09D11/52
Filed: 2019-07-03
Abstract: L'invention concerne une composition (encre) comportant des nano-objets métalliques pour la préparation d'un film électroconducteur transparent. La composition comprend un liquide porteur choisi parmi des liquides polaires non aqueux et des nanoparticules métalliques dispersées dans ledit liquide porteur, la surface des nanoparticules étant au moins partiellement revêtue d'une couche comprenant un ou plusieurs composés de Sn (ll) qui sont solubles dans le liquide porteur.
Patent WO-2020011752-A1 (WO)
Title: Antibodies having specificity for the orf2i protein of hepatitis e virus and uses thereof for diagnostic purposes
Inventor: COCQUEREL-DEPROY LAURENCE
IPC: G01N33/576
Filed: 2019-07-09
Abstract: Hepatitis E virus (HEV) is annually responsible for 20 million infections with 3.4 million symptomatic cases and 70,000 deaths mainly occurring in less developed regions of the world. HEV is a quasi-enveloped virus containing a linear, single-stranded, positive-sense RNA genome that contains three open reading frames (ORFs), namely, ORF1, ORF2 and ORF3. ORF2 encodes the ORF2 viral capsid protein, which is involved in particle assembly, binding to host cells and eliciting neutralizing antibodies. Recently, 3 different forms of the ORF2 capsid protein were identified: infectious/intracellular ORF2 (ORF2i), glycosylated ORF2 (ORF2g), and cleaved ORF2 (ORF2c). The ORF2i protein, for which the precise sequence has been identified, is the form that is associated with infectious particles and thus antibodies having specificity for the ORF2i protein would be suitable for the diagnosis of HEV. The present fulfills this need by providing an antibody which binds to the ORF2i protein of hepatitis E virus and wherein said antibody does not bind to the ORF2g protein nor to the ORF2c of hepatitis E virus, and wherein the epitope of said antibody comprises at least one amino acid residue from amino acid residues 10 to 23 of SEQ ID NO: 1.
Patent WO-2020038975-A1 (WO)
Title: Roboterregelung
Inventor: SEDLMAYR ANDREAS
IPC: B25J9/16
Filed: 2019-08-21
Abstract: Bei einem erfindungsgemäßen Verfahren zur Regelung eines Roboters (1) wird wenigstens ein Gelenkregler (31-36) zur Verstellung eines Gelenks des Roboters auf Basis einer Pose des Roboters und einer vorgegebenen Kraft- und Positions-Gewichtung wenigstens eines kartesischen Freiheitsgrades einer roboterfesten Referenz verstellt (S20).
Patent WO-2020053026-A1 (WO)
Title: Electric field reducing insulating layer for an inductive coil
Inventor: JANSEN JACOB WILLEM
IPC: H01F38/14
Filed: 2019-09-03
Abstract: A device comprises a first coil (15) comprising at least one first winding (153) of an electrical wire, the first coil arranged for being driven at a first voltage. A solid insulating layer (26) is adjacent the first coil and has a first surface (265) facing the first coil. The first surface of the solid insulating layer comprises a first groove (263) between the at least one first winding (153) and the insulating layer having a width (w) smaller than a diameter (D) of the electrical wire.The first groove (263) forms a pocket (267) between the at least one first winding and the solid insulating layer.
Patent WO-2020126143-A1 (WO)
Title: Vorrichtung und verfahren steuerung der ausgabe von fahrerinformation und zur aufrechterhaltung der aufmerksamkeit eines fahrers eines automatisierten fahrzeugs
Inventor: SCHULZ MICHAEL
IPC: B60W50/14
Filed: 2019-10-01
Abstract: Es wird eine Vorrichtung und ein Verfahren zur Steuerung der Ausgabe von Fahrerinformation an einen Fahrer eines Fahrzeuges vorgeschlagen mit dem Ziel, den Fahrer und/oder die Insassen des Fahrzeugs zu unterhalten und/oder die Fahreraufmerksamkeit des Fahrers zu erhöhen. Hierzu ist eine Datenbank mit Sehenswürdigkeiten bzw. Objekten von allgemeinem Interesse vorgesehen, eine Datenbank topografischer Informationen vorgesehen, eine Einrichtung zur Bestimmung des Aufenthaltsortes des Fahrzeugs vorgesehen und eine Auswerteeinrichtung vorgesehen, der diese Informationen zugeführt werden. Diese Auswerteeinrichtung ermittelt aus dem momentanen Aufenthaltsort des Fahrzeugs und der topografischen Information, welche Sehenswürdigkeiten bzw. Objekte von allgemeinem Interesse im Blickfeld des Fahrers liegen und gibt über eine Ausgabeeinrichtung die Fahrerinformation zu der Sehenswürdigkeit bzw. zu dem Objekt von allgemeinem Interesse aus, das durch die Auswerteeinrichtung als im Blickfeld des Fahrers liegend, ermittelt wurde.
Patent WO-2020078798-A1 (WO)
Title: Method for the production of acrylic acid or salts thereof
Inventor: GHISLIERI DIEGO
IPC: C12P7/40
Filed: 2019-10-09
Abstract: The invention is directed to methods for the production of ammonium acrylate or salts thereof from acrylonitrile using nitrilase as catalyst.